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1. Abstract 
Background: 
There is an increasing amount of blood sample rejection at primary level health care 
facilities which impacts negatively on the staff, facility, patient and laboratory and resulting 
in escalating financial costs. The result of a pilot audit has shown that this rejection is 
predominantly related to incorrect phlebotomy technique.  
 
Purpose: 
To develop an effective sustainable intervention that will contribute in decreasing the 
rejection rate of blood samples by the laboratory in four different community health centres 
(CHCs) in Cape Town.  
 
Objectives: 
1. To conduct a pre training audit investigating the rejection rate of all routine blood 
samples and reasons for blood sample rejection taken at four different CHCs in Cape 
Town. 
2. To implement a training programme with appropriate sustainable interventions that will 
ultimately benefit the staff, patient, facility and the laboratory. 
3. To conduct a post training audit investigating the rejection rate and reasons for blood 
sample rejection at four different CHCs in Cape Town. 
4. Study participants will complete the same phlebotomy questionnaire pre and post 
training to assess whether knowledge regarding phlebotomy has improved post training. 
 
Study Design: 
Two components: retrospective cross sectional and before-after study design. 
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Study Setting: 
Multi-centre study conducted at four CHCs in Cape Town, two 24- hour facilities and two  
8-hour facilities. The CHCs include Mitchells Plain, Hanover Park, Heideveld and Maitland. 
  
Study Population: 
The population groups that will be used in the three components of the study include: 
1. Pre-training audit: The study population will include all routine blood samples (adults 
and children) taken, sent and rejected at the four CHCs over the audit period. 
2. Intervention: 6 -10 staff members involved in phlebotomy will be invited to attend the 
training session and the members will be selected by convenience sampling. Members 
will be asked to complete a piloted pre and post training phlebotomy questionnaire. 
3. Post-training audit: The study population will include all routine blood samples (adults 
and children) taken, sent and rejected at the four CHCs following the training session. 
 
Study Sample: 
Consecutive sampling of blood samples, convenience sampling of staff members to the 
intervention. 
 
Data Collection Methods: 
The NHLS database will be used to determine the rejection rate and reasons for blood 
sample rejection. A closed- ended questionnaire will be used pre and post training. 
 
Statistical Methods: 
Basic statistics, including proportions and corresponding confidence intervals will be 
determined.  
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2. Introduction 
2.1 Literature Review 
Patient care and safety has become increasingly more important in laboratory 
medicine.1Clinical governance is a system where healthcare organisations are responsible 
for continuously improving the quality of services that positively impacts on patient care.1,2 
It is described as “a framework through which organisations are accountable to continue to 
improve the quality of the service and safeguard high standards of care by creating an 
environment in which excellence in clinical care would flourish”. 3 
Clinical laboratories are striving to decrease the rejection rate of unsuitable blood samples 
and to provide an excellent level of care with increasing attention paid to patient care and 
safety.2 The International Organization for Standardisation defines laboratory error as 
“failure of a planned action to be completed as intended, or use of a wrong plan to achieve 
an aim, occurring at any part of the laboratory cycle, from ordering examinations to 
reporting results and appropriately interpreting and reacting to them”.4 
The National Health Laboratory Service (NHLS) is the provider of laboratory services to all 
public sector hospitals in South Africa and certain requirements are necessary before a 
sample can be successfully processed. Majority of blood samples are rejected as a result of 
pre-analytical errors and this accounts for up to 70% of laboratory errors.5 Pre-analytical 
laboratory measures includes the following:1,2 
 Patient identification (labelling errors, no test specified on request form, illegible 
request). 
 Sample collection (clotting, insufficient volume, inappropriate sample container, 
haemolysis). 
 Sample transport (storage conditions i.e. temperature, sample lost or not received by 
laboratory). 
The absolute prevalence of pre-analytical problems ranged between 0.2% - 0.75% in a 
review on risk management, with the most common errors being haemolysis, clotting, 
insufficient blood volume, wrong sample tube and misidentification.6 There was a 6.4%- 
12% chance of inappropriate care due to laboratory errors, with up to 30% of errors 
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resulting in patient discomfort, escalating financial costs as well as subjecting patients to 
repeat blood tests.6 Risk reduction in the pre-analytical phase is essential in improving 
quality and patient satisfaction as this is one of the most important phases to impact on 
patient outcomes and healthcare costs.  
In a recent retrospective audit conducted at Tygerberg hospital in Cape Town, investigating  
the rejection rate of blood samples, the reasons for blood sample rejection and the clinical 
impact on patient care, it was shown that 481 samples out of a total of 32 910 were rejected 
during the two week study period with a rejection rate of 1.46%. 1The two main reasons for 
sample rejection were clotting (30%) and inadequate sample volume (22%).1 Haemolysis 
account for 40-70% of all unsuitable blood samples sent to the laboratory and is much 
higher than any other causes such as clotted samples, incorrect blood volume, and incorrect 
sample tubes used. 7The low frequency and delay in repeating the blood sample is also a 
concern as laboratory results can influence clinical decisions.8   
A critical value is defined as a “result suggestive of imminent danger to the patient unless 
appropriate therapy is promptly initiated”. An awareness of the clinical and economic 
impact of blood sample rejection can be created by communication between clinicians and 
laboratory staff, using the current guidelines available on specimen sampling and education 
of staff.10 
The evaluation of the reasons for blood sample rejection and its impact on healthcare costs 
as well as costs to the staff and most importantly to the patient is a form of health systems 
research. Health systems research is a form of research that aims to provide information 
which will improve the functioning of a health system, which will lead to improved health 
status.11 
The Commission on Health Research for Development identified international health 
research partnerships as vital to advancing health in developing countries and promoting 
global health equity.12The World Health Organisation (WHO) and global ministerial summits 
have subsequently linked health research to achieving the United Nations Millenium 
Development Goals (MDG’s).13,14  Stronger health systems are vital to  achieving improved 
health outcomes.14 
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Strengthening health systems in developing countries is essential in improving healthcare 
globally and in reaching the MDG’s. Most developing countries fall short of the 
requirements to implement the goals suggested by the WHO.16 The following are important 
components, proposed by the WHO, in strengthening health systems and in achieving an 
effective public health system: service delivery, financing, governance, the health 
workforce, information systems and supply management systems.17 
One of the main goals in strengthening health systems should be improving clinical and 
public health laboratories13 and this includes reducing the rejection of blood samples sent to 
the laboratory. A recent conference evaluating a program for strengthening laboratory 
management was held in Africa in 2009. The highlights of this conference was to “act now, 
act collectively and act differently to ensure sustainability of global health efforts to 
enhance laboratory networks and systems”18.  
Acting now involves addressing the 3 pillars for disease prevention, control, and patient 
management which include public health, clinical medicine, and laboratory medicine. The 
most neglected pillar in developing countries is laboratory medicine and this is important in 
clinical decision making. The increase in funding for global health development19,20 provides 
a good opportunity to end the neglect of laboratory systems and services in global health in 
developing countries. Quality laboratory services and systems is important in strengthening 
health systems as laboratory medicine provides critical information that aids in clinical 
decision making.18Acting collectively involves addressing laboratory strengthening in a 
holistic way and to form partnerships to support developing countries to strengthen 
laboratory systems. Acting differently involves recognising the importance of clear 
indicators in order to monitor progress in strengthening laboratory systems.18 
The first international conference of the African Society for Laboratory Medicine (ASLM) was 
held in Cape Town, South Africa in December 2012. The focus of the conference was to 
strengthen national laboratory health systems. The outcomes of this conference was that it 
aimed to meet the following targets by the year 2020: “certification of 30,000 laboratory 
staff, the harmonisation in the regulation of diagnostics in Africa’s five economic regions, 
the international accreditation of 250 laboratories, and the strengthening of an African 
Network of National Public Health Reference laboratories in 30 countries.”21 
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The National Health Insurance (NHI) is a financing system that will ensure that all South 
Africans have access to essential healthcare irrespective of their employment status. The 
NHI will be piloted in 10 districts over a 5 year period with an audit being conducted of all 
public health facilities in the country. During the first 5 years of NHI, the focus will be on 
strengthening the health system in the following areas: management of health facilities, 
quality improvement, development of infrastructure, medical equipment, management of 
human resources, information management and systems support and development of an 
NHI fund.22 The NHI will contribute to strengthening laboratory health systems and reduce 
the escalating financial costs of rejected blood samples at primary level.  
 
2.2 Motivation for study: 
The motivation for this study was based on the results of a pilot audit conducted by the 
principal investigator in 2012 at Vanguard Community Health Centre (CHC). 
A CHC is a public health care facility funded by the government. It focusses on providing 
primary health care by covering a range of health promotion, disease prevention, curative 
and rehabilitative services to the community. 23,24  
An uncontrolled non-validated pilot audit was conducted by the principal investigator in 
August 2012 at Vanguard CHC. In this audit, it was found that 81 blood samples out of a 
total of 1117 were rejected in the two week audit period which correlated to a rejection 
rate of 7.3%. The most common reasons for sample rejection were haemolysis (46%), 
followed by no sample tube received by the laboratory (26%). Only adult blood samples that 
were taken, sent and rejected were included in this audit.  
Other costs of blood sample rejection at the CHC include costs to the staff, patient, facility 
and the laboratory. The costs to the staff include having to request the folder and either call 
the patient back or post a letter to the patient’s home. This then resulted in one less doctor 
seeing patients in the clinic and thus a delay in the flow of patients. A delay in obtaining 
urgent results compromises patient care as important clinical decisions cannot be made 
during the current hospital visit. The costs to the patient include financial strain (borrowing 
money or using own money for public transport to access the CHC), a day off work and 
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being pricked again for another blood sample. The cost to the facility includes paying for the 
phlebotomy equipment. Costs to the laboratory include paying for the rejected blood 
samples, the sample tubes and the paper and ink used to print the rejected results to the 
facility. 
Following the results of the audit at Vanguard CHC, interventions were put in place in order 
to decrease the rejection rate at the facility. The results of the audit were presented to the 
staff of Vanguard CHC.  The results were also presented at the combined University of Cape 
Town (UCT) and Metro District Health Services (MDHS) workshop. 
Interventions included posters highlighting which samples tubes to use for the requested 
blood test and the volume of blood required per blood test, education of staff regarding 
criteria for sample acceptability, a poster highlighting the modified criteria for sample 
acceptability was put up on the wall in the phlebotomy room for nurses to use as a guide, 
checking of samples on a daily basis and the nurse responsible for checking the samples to 
sign the “daily sample checklist”, which is handed to the facility manager on a weekly basis, 
record keeping of all samples drawn as well education and training of staff regarding correct 
phlebotomy technique. Additional phlebotomy equipment were also ordered to reduce the 
risk of haemolysis as a cause for sample rejection.  
A formal phlebotomy training session was held at Vanguard CHC on 4 April 2013, 28 
members of the facility attended the training session which included doctors, nurses and 
students. The training was conducted by a qualified phlebotomist employed at the NHLS 
Greenpoint laboratory. At this training session all the basic principles of good phlebotomy 
technique was highlighted with a practical demonstration. Each member received a copy of 
the “specimen sampling manual” which outlines all the principles of phlebotomy. 
  
2.3 Research question 
Is training of staff regarding phlebotomy associated with a decrease in rejection rate of 
blood samples by the laboratory, as compared to no training? 
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2.4 Aim 
To develop an effective sustainable intervention that will contribute in decreasing the 
rejection rate of blood samples by the laboratory in four different CHCs in Cape Town.  
 
2.5 Objectives: 
1. To conduct a pre training audit investigating the rejection rate of all routine 
blood samples and reasons for blood sample rejection at four different CHCs in 
Cape Town. 
2. To implement a training programme with appropriate sustainable interventions 
that will ultimately benefit the staff, patient, facility and the laboratory. 
3. To conduct a post training audit investigating the rejection rate and reasons for 
blood sample rejection at four different CHCs in Cape Town. 
4. Study participants will complete the same phlebotomy questionnaire pre and 
post training to assess whether knowledge regarding phlebotomy has improved 
post training. 
  
3. Methodology 
3.1 Study Design: 
This study will consist of two components: Firstly, a retrospective cross-sectional study 
design will be used to determine the rejection rate and reasons for blood sample rejection 
at four CHCs in Cape Town. The laboratory information system of the NHLS DISALAB will be 
used to extract the number of routine blood samples that was performed and rejected over 
the audit period as well as the reasons for blood sample rejection.  
Secondly, a before-after study design will be used to determine the rejection rate before 
and after the intervention.   
This section was conducted in five steps: 
1. Pre-training audit at each of the four identified CHC’s to determine the rejection rate 
and reasons for blood sample rejection. 
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2. Training of staff in one session at each of the identified CHCs with the same pre and 
post training phlebotomy questionnaire. 
3. Post-training audit at each of the four CHCs that received training. 
4. Analysing the data of the audit pre and post training. 
5. Analysing the data of the pre and post training questionnaire. 
  
3.2 The Intervention 
See Annexure 2 
 
3.3 Study Setting 
A multi-centre study at four CHCs in Cape Town, two 24 hour facilities and two eight hour 
facilities. The CHCs include Mitchells Plain, Hanover Park, Heideveld and Maitland. 
 
3.4 Study Population:  
The population groups that will be used in the three components of the study include: 
1. Pre-training audit: The study population will include all routine blood samples (adults 
and children) taken, sent and rejected at the identified four different CHCs over the 
audit period.  
2. Intervention: 6 -10 staff members will be invited to attend the training session and the 
members will be selected by convenience sampling.  
3. Post-training audit: The study population will include all routine blood samples (adults 
and children) taken, sent and rejected at the identified four different CHCs following the 
training session. 
 
 
 
 
 
14 
 
3.5 Sampling: 
Sampling of blood samples: Consecutive sampling will be done from the number of blood 
samples sent to the NHLS by the four facilities. No random allocation to the intervention will 
be done.  
Sampling of staff for training (intervention): Convenience sampling of staff members to the 
intervention will be done on the day of training. The comparison will be time based (before 
and after the intervention).  
 
3.5.1 Inclusion Criteria: 
The study will include the following routine blood samples and staff members.  
Blood samples: 
 All blood samples including children and adults of all ages. 
 Bloods drawn via any phlebotomy technique i.e. needle and syringe, needle and bull 
dog and butterfly needle and syringe.  
 Bloods drawn from any site on the body i.e. arm, leg etc 
 Arterial and venous blood. 
 Bloods drawn by any member of the health care team including doctors, nurses, 
medical students, nursing students, interns, community service doctors and locum 
nurses or doctors will be included.  
 Bloods drawn from any area of the CHC which includes emergency department, 
injection room, INR room, doctors consultation room, club room. 
Staff members:  
Approximately 6-10 staff members involved in phlebotomy at the CHC who are available on 
the day of training will be invited to participate in the study. 
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3.5.2 Exclusion criteria:   
 All blood samples that are not drawn at the four CHCs where the audit will be 
conducted. 
 Urine, stool, sputum, pleural fluid, ascitic fluid, FNABS and PAP smears. 
 Staff that are not involved with phlebotomy e.g. admin staff, cleaners. 
 
 
3.6 Recruitment 
Participants for the phlebotomy training session will be recruited by sending an email 
to the facility managers and family physicians at the four CHCs. Posters will also be put 
up on the walls at the CHCs. 
 
3.7 Data Collection and Management 
The data for this study will be extracted from the NHLS DISALAB at the data warehouse in 
Johannesburg. This information will be emailed to me in the form of an excel document. The 
list of variables to be collected/extracted includes the total number of routine blood 
samples performed and rejected blood samples over the audit period, the name of the 
tested that was rejected e.g full blood count and the reason for the blood sample being 
rejected e.g. clotted sample. Illegible or inconsistent entries will be excluded from the study 
and reported on. No patient details will be provided as this is not required for the purpose 
of the study. The data collection tool will be a data capture sheet (see Annexure 1).  
Data from the data capture sheets will be captured onto Microsoft Excel, where it will be 
backed up on external USB storage devices which will only be accessible to the principal 
investigator and supervisors of this study, members of the University of Cape Town and the 
Department of Family medicine as well as staff at the NHLS. The data will also be encrypted 
and password protected within Microsoft Excel to limit access to the principal investigator 
and supervisor upon request. 
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The same pre and post training questionnaire will be completed by all staff attending the 
training session. It is a closed ended questionnaire comprising of 20 questions and will be 
translated into one other language Afrikaans. The questionnaire was developed based on 
the NHLS phlebotomy training manual 2013. The questionnaire will be piloted by staff 
ordering blood investigations or involved in phlebotomy at Vanguard CHC.  
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4 Statistical and Data Analysis 
4.1 Sample Analysis 
The primary analysis method in this study will be the calculation of the proportion and 
corresponding confidence interval for the rejection rate from the retrieved data from NHLS. 
The required sample size was based on this proportion and achieving the desired precision 
in the 95% confidence interval. The power of the study will be set at 90% and the α value 
will be set at 0.05. A sample size of 742 is needed using the above power and α value and 
using the rejection rate of 7.3% from the pilot audit. Consecutive sampling of blood samples 
will be done to reach a minimum number of 742 samples. The number of rejected samples 
and subsequent rejection rate will be determined from this sample. 
 
4.2 Data Analysis 
Microsoft ExcelTM will be used to capture the data and STATISTICATM version 10 will be used 
to analyse the data.  
The primary objective of the study is to determine whether training of staff is associated 
with a decrease in the rejection rate of adult blood samples in four CHCs in Cape Town. 
A p-value of < 0.05 will represent statistical significance in hypothesis testing and 95% 
confidence intervals will be used to describe the estimation of unknown parameters. 
 
5 Ethical and Legal Considerations 
Patient/participant confidentiality will be maintained throughout the study. For the pre and 
post training audit, a waiver of consent will be requested as no patients will be directly 
involved or contacted. A study identity without any external meaning will be allocated to 
each record. Written consent will be obtained from all staff participating in the training 
programme (Annexure 3). Each participant in attendance at the training will complete the 
same pre and post training questionnaire and a number will be allocated to each 
questionnaire to protect the identity of the participant completing the questionnaire. All 
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staff participating in the study will be informed of the background, aims and objectives of 
the study. Permission will be obtained from the data warehouse of the NHLS in 
Johannesburg to obtain the number of samples received and rejected and reasons for blood 
sample rejection at the  four CHC’s in Cape Town. This information will only be provided 
once the study has gained ethics approval from the Human Research Ethics Committee 
(HREC) at the University of Cape Town.  
 
6 Limitations 
The study is limited by its retrospective design based on pre-collected records that may be 
incomplete. The study is only investigating the rejection rate and reasons for blood sample 
rejection at four CHCs in Cape Town and the interventions will only be instituted at these 
four facilities. The study will also be limited to CHCs and no district, secondary or tertiary 
hospitals will be included. The private sector will be excluded from the study. 
All staff involved in phlebotomy might not have been exposed to the intervention as they 
may have been absent or sick on the days that training was done. The recruitment process 
of participants into this study as well as illegible or inconsistent results from NHLS may 
affect internal validity.  
The training session will be done in English. The participant information leaflet and the study 
questionnaire will be made available in two languages, English and Afrikaans. A non –
validated closed-ended questionnaire will used.  
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7 Resources 
7.1 Available Resources  
     Description Source 
1. Statistical services Centre for Statistical 
Consultation, University of Cape 
Town 
2.  Travel Services Principal Investigator 
3. Telephone Services Principal Investigator 
4. Internet access and email facilities Principal Investigator 
5. Access to Microsoft excel and Microsoft 
word  
Principal Investigator 
6. Printing and copying Principal Investigator 
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7.2 Budget 
STUDY BUDGET 
March 2013 – December 2014 
Item   Description Unit cost No. of 
units 
Total cost 
1. Communication Phone, 
internet, email 
R100/month 8 R800.00 
2. Travel to sites Travel cost  R3.61/km 200 R722.00 
3. Office supplies, 
printing, 
laminating, 
photos for 
posters 
Printing R0.40/page 1000 R400.00 
4. Juice and 
snacks for 
Training 
Eatables R150 4 R600.00 
5. Specialised 
services 
Bio statistical 
services 
No cost 10  
 Phlebotomist 
assisting with 
training 
No cost   
 Dummy IV arms R3100.00 1 R3100.00 
 Phlebotomy 
equipment for 
demonstration 
No cost   
TOTAL    R5622.00 
 
 
8 Reporting and Implementation of Results 
Once the study has been completed, the results of the study will be made available to all 
participants and members of the four CHCs where the study was conducted, members of 
the NHLS and the UCT division of Family Medicine as well as key provincial members 
responsible for decision making in the metro-district health services. The study will be 
published as a journal article and contribute to evidence based medicine and will serve as a 
platform for further research into strengthening laboratory health systems.  
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ANNEXURE 1 
DATA CAPTURE SHEET 
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ANNEXURE 2 
THE INTERVENTION 
Background: 
Phlebotomy refers to the process of making an incision in a vein. It is associated with 
venipuncture which is the practice of collecting venous blood samples.1 
Phlebotomy training is important as it provides the trainee with the necessary theoretical 
and practical knowledge in phlebotomy which will enable you to carry out your task 
effectively and confidently. The training also highlights the health and safety measures of 
phlebotomy. The training teaches the trainee the proper venipuncture technique to draw 
blood, the right way to control and handle materials including blood samples as well as 
phlebotomy equipment such as needles and syringes. 2 
The training session for the study will be approximately one to two hours long and will be 
conducted at each of the four identified CHCs (Mitchells Plain, Hanover Park, Heideveld and 
Maitland) at a pre-determined time which will be most convenient for the staff.  It will be 
based on the “NHLS Western Cape Regional Laboratories Specimen Sampling Manual 2013”. 
The manual is used as a guide to everyone involved in taking specimens that are sent to the 
NHLS. The diagnostic information from the laboratory is dependant on the adequacy and 
quality of the sample and request form received.  All staff members who attends the 
training session will receive a copy of the “NHLS Western Cape Regional Laboratories 
Specimen Sampling Manual 2013”. 
A pre and post training questionnaire will be completed by each staff member who attends 
the training to see if their knowledge has improved post training.  
 
Purpose:  
The purpose of the phlebotomy training session is to equip nursing students, doctors and 
nurses in proper phlebotomy technique. It is not meant to teach trainees phlebotomy from 
scratch as trainees do have prior experience and many have been working at the CHCs for 
many years. It is meant to advise on proper technique, to address problems and concerns, 
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to add to existing knowledge and to strengthen skills. The content includes performance of 
safe and efficient work practices in obtaining adequate and correct blood specimens by 
venipuncture on adults3, maintaining the integrity of the specimen in relation to the test to 
be performed, labelling specimens accurately and completely, promoting the comfort and 
well-being of the patient while performing blood collecting, checking the request form and 
phlebotomy equipment prior to drawing blood. 
 
Exit level outcomes: 
After completion of the training programme, the trainee should be able to correctly 
complete a sample request form and demonstrate the skills and knowledge to perform 
phlebotomy. 
 
Specific outcomes: 
On completion of this phlebotomy training programme, the trainee will be able to: 
1. Understand the importance of correct completion of the sample request form. 
2. Understand the equipment used for phlebotomy. 
3. Demonstrate skills and knowledge necessary to perform phlebotomy. 
4. Implement the “Criteria for specimen acceptability” with every blood sample drawn. 
 
Lesson Plan: 
Module: Phlebotomy training  
Topic: Strengthening knowledge and skills related to phlebotomy 
Venue: Flat carpeted room at community health centre 
Facilitators: Dr M. Abbas; Phlebotomist from NHLS 
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Learning Aids:  
1. Laptop 
2. Projector screen 
3. Table for snacks and drinks 
4. Chairs for staff 
5. “Dummy IV arms” 
6. Phlebotomy equipment: request forms, sample tubes, syringes, needles, butterfly 
needles, luer adaptors. 
7. Copy of “specimen sampling manual 2013” for each member in attendance. 
  
Programme: 
07:30 -08:00: Welcome staff, Introduction, discussion on common problems that staff are 
experiencing at CHC regarding anything related to phlebotomy. Interactive 
session to address concerns. Obtain informed consent for participation in 
study. 
08:00 – 08:10: Very brief PowerPoint presentation. Background on why phlebotomy training           
                           is important and results of pilot audit at Vanguard CHC. 
 
08:10- 08:25:  Pre training questionnaire 
 
08:25- 09:15:   Training. Interactive session including opportunity to practice technique on  
“dummy IV arms”. Address questions and concerns. 
 
09:15 – 09:30: Questions and post training questionnaire 
 
09:30:   Snacks and closure 
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Assessment Criteria: 
Trainees will be assessed using the same questionnaire pre and post training. There will be 
no pass mark. The score pre and post training will determine whether knowledge around 
phlebotomy has increased. Trainees will have an opportunity to practice their skills on the 
“dummy IV arms”. 
 
Instructors guide: 
The training session will cover the following areas related to phlebotomy:4 
1. Introduction and general instructions 
1.1. Equipment check before proceeding with venepuncture 
 correct request form for a CHC, enquire where the request forms are kept 
  butterfly needles, 23G best to use 
  green and black needles 
  5ml and 10ml syringes 
 Webcols to clean skin 
 Luer adaptors 
 “bull dogs” with adaptors 
 Samples tubes of different colours 
 Sharps container 
 Tape and cotton wool for application to site of venepuncture 
 Gloves 
 Tourniquet 
 
1.2. Sample collection times by driver of NHLS 
Staff need to be aware of the daily collection times of blood samples and if there 
is a driver that collects samples after hours. Is the collection time documented by 
staff? 
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1.3. Sample storage conditions 
Samples should be stored at room temperature at 15 - 30⁰C, out of direct 
sunlight. All Purple top samples should reach the laboratory within 24 hours.  
Full blood count (FBC), Potassium , Creatinine, INR and CD4 samples must be sent 
to the laboratory within 24 hours and can be kept in the fridge on a hot day while 
awaiting transport. Potassium must be processed by the laboratory within 8 
hours from the time of sample collection to prevent a falsely elevated potassium 
reading. The fridge temperature must be set at a maximum temperature of 2-8⁰C 
and samples should not be kept close to the freezer. Do not pour blood from one 
sample tube into another as this will also result in incorrect blood results.  
 
Sample tubes (before blood is drawn) must NOT be kept in the fridge as this 
causes the red blood cells to rupture causing haemolysis when warm blood 
enters the cold sample tube.  
 
1.4. Samples sent to different laboratories 
If you are drawing blood which will be processed by two or more laboratories 
e.g. haematology (FBC) and chemical pathology (HBA1c), which both require 
purple top tubes then send two samples as specimens can get lost between 
laboratories or one sample tube might not have enough blood to process two 
tests.  The test may then be rejected by the laboratory as “insufficient specimen” 
or “specimen not received by lab” 
 
1.5. Record of bloods drawn and rejected 
Does the facility keep a record of daily bloods drawn and rejected? How is this 
documented and what measures have been taken to improve the current 
system? 
 
2. Technique for venepuncture and specimen handling: 
2.1. Patient identification 
Greet the patient and identify yourself and ensure that you are taking the correct 
patients blood. 
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2.2. Criteria for sample acceptability, the Modified “Abbas Tool”  (see   
           attached) 
 
2.3. Order of draw of samples 
Blood samples have to be drawn in the following order to avoid cross-
contamination of additives between tubes. 
 blood culture (this is not done at the CHC) 
 yellow top 
 blue top 
 grey top 
 purple top 
 
2.4. Venepuncture site collection 
The veins of choice are the median cubital and cephalic veins of the arm. Veins 
on the wrist and hands can also be used. 
 
Areas to avoid during venepuncture:  
 Scars from burns and previous surgery. 
 Upper extremity on the side of a previous mastectomy  as test results may 
be affected by lymphoedema. 
 Haematoma – if this develops then choose another site or go distal to the 
haematoma. 
 Intravenous therapy (IV) or blood transfusions – fluid dilutes the 
specimens and alters the test result. Samples should be collected from 
the opposite arm. Samples may be drawn below the IV site as follows: 
o Turn off IV for 2 minutes before venepuncture 
o Place tourniquet below IV site 
o Choose a suitable vein but not the vein where the IV is inserted. 
o Draw 5ml of blood from the selected vein and discard the blood. 
o Then draw the blood required for the sample tubes. 
   Oedematous extremities – fluid in the tissues also alters test results. 
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Procedure for vein selection: if superficial veins are not easily seen or felt, massage the arm 
from wrist to elbow to force blood into the vein. Tapping the vein with one or two fingers 
and placing a warm damp cloth onto the vein for 5 minutes, lowering the extremity over a 
bed or chair also allows the veins to fill. 
 
2.5. Performance of a venepuncture 
The patient should be approached in a friendly manner, make the patient 
comfortable and explain what you are about to do. 
 Ensure that blood is being drawn on the correct patient. 
 Complete the request form correctly 
 Position the patient correctly: patient should sit in chair, lie down or sit up 
in the bed. The arm should be hyperextended. 
 Apply the tourniquet 3-4cm above the puncture site. Do not apply the 
tourniquet too tight. Do not leave the tourniquet on for more than 2 
minutes.  
 Use an alcohol preparation like webcol to prepare the patient’s arm and 
clean in a circular manner, starting at the site and moving outward, 
allowing the area to air dry. 
 Draw the patient’s skin taut with your thumb and stabilise the vein. Ensure 
that the needle forms a 15-30 degree angle with the surface of the arm 
and insert the needle through the skin and into the lumen of the vein. 
Avoid trauma and probing. 
 Release the tourniquet when the last sample tube is filling. 
 The needle should be removed from the patient’s arm in a swift backward 
motion 
 Once the needle is removed, apply gauze pressing down firmly to avoid a 
haematoma. 
 Do not ask the patient to bend the arm as the tension of the two muscles 
causes bruising. 
 Dispose of all sharps in the sharps container 
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 Mix the tubes gently and label correctly placing the patient’s sticker length 
wise on the tube and not over the cap. Do not pre-label sample tubes. 
 Place collected samples in the appropriate collection box for collection by 
the driver to the NHLS. 
 
2.6. Additional considerations. 
2.6.1 Preventing a haematoma 
 Only puncture the upper most wall of the selected vein. 
 Remove the tourniquet before removing the needle. 
 Use the major superficial veins. 
 The needle must penetrate the upper most wall of the vein as partial 
penetration will cause blood to leak into the soft tissue surrounding the 
vein. 
 Adequate pressure should be applied to the site of venepuncture. 
                       2.6.2. Preventing haemolysis 
 Mix tubes gently 8-10 times by gentle inversion, do not shake as this will 
cause haemolysis. Failure to mix adequately can result in the formation of 
a clot which may render the sample unsuitable for analyses. 
 Do not draw blood from a haematoma. 
 Do not draw the plunger back too forcefully when using a syringe and 
needle and avoid frothing the sample. 
 Do not force blood into the sample tube, but allow the blood to run into 
the tube spontaneously when using a needle and syringe. 
 When using a butterfly needle to draw blood, discard the butterfly needle 
and attach a new needle to the syringe and then transfer the blood into 
the sample tube. 
 In patients with small veins, one can also use a butterfly needle with a luer 
adaptor and use the “bull dog” to obtain blood. 
 Ensure that the site of venepuncture is dry. 
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 Avoid a traumatic venepuncture or probing. 
                        2.6.3 Haemoconcentration 
Factors that result in an increased concentration of larger molecules and 
formed elements in the blood include: 
 Prolonged tourniquet time of more than 2 minutes. 
 Massaging, squeezing or probing a site. 
 IV therapy 
 Sclerosed or occluded veins 
 
2.7. Troubleshooting guidelines 
Incomplete blood sample collection or no blood obtained: 
 This is corrected by changing the position of the needle, moving it forward 
(needle might not be in lumen)or backwards (needle might have 
penetrated too far). 
 Adjust the angle as the bevel of the needle may be against the wall of the 
vein. 
 Loosen the tourniquet to ensure that there is no obstruction to blood flow. 
 Use another sample tube as the previous one may have no vacuum. 
 Re-stabilise the vein as it may have moved from the point of the needle 
and puncture site. 
                        If blood stops flowing into the tube:  
 This can occur if the vein collapses, re secure the tourniquet to increase 
venous filling. 
 If this is unsuccessful then remove the needle and redraw from a different 
site. 
 The needle may also have pulled out of the vein while switching sample 
tubes. The equipment should be held firmly with fingers against the 
patient’s arm, the flange to be used as leverage when withdrawing and 
inserting tubes.  
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                         Other problems: 
 If a hematoma forms under the skin at the puncture site, immediately 
release the tourniquet and withdraw the needle and apply firm pressure. 
 If arterial blood is drawn instead of venous blood then apply pressure for 5 
minutes. 
References for intervention: 
1. Phlebotomy. Available from: en.wikipedia.org/wiki/Phlebotomy . [Accessed 10 July 2013] 
 
2. Importance of phlebotomy training. Available from: 
http://www.phlebotomycertification.co.uk/importance-of-phlebotomist-
training/.[Accessed 10 July 2013] 
3. Zivkovic C. Instructors guide for training phlebotomists. 2006. Available from: 
www.pte.idaho.gov/pdf/health/curriculum/phlebotomycurriculum.pdf 
 
4. Quality Managemnet working group. The National Health Laboratory Service Specimen 
Sampling Manual 2013, version 7. 
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1. REQUEST FORM 
 Name of facility 
 Diagnosis 
 Name of requesting doctor 
 Date and time of sample collection 
 Person who took specimen 
 Test specified on request form 
 Legible request 
 Patient’s details (first name & surname, folder no, age/DOB, sex) 
 Correct specimen type for test requested 
 Doctor’s signature 
 INR sample – working contact number of patient or doctor 
2. SAMPLE  
 Tube not expired (check expiry date on tube)/cracked 
 Correct colour tube 
 Labelled specimen (sticker placed lengthwise, NOT covering cap): 
First name and surname, folder no OR sticker if available 
 Do not pre-label before drawing blood 
 Patient’s name on form and specimen matching 
 Correct volume of blood (check volume required on tube) 
 Gentle mixing of sample 8-10 times 
 Sample tubes kept at room temperature, NO direct sunlight 
 Samples kept at room temperature, IN FRIDGE if after hours 
3. SAMPLE TRANSPORT 
 Sealed packet 
 Blood sample/s and request form of index patient  in one packet 
References:  
1. Jacobsz LA, Zemlin AE et al. Chemistry and haematology sample rejection and clinical impact 
in a tertiary laboratory in Cape Town. Clin Chem Lab Med. 2011: 49(12): 2047-2050. 
2. Lab informants: Anthony Williams, Sr. Petersen, Mogamed Davids, Almaree Kline at NHLS 
(August/September 2012). 
 
MODIFIED ABBAS TOOL: 
Criteria for Specimen Acceptability 
Compiled by: Dr. M. Abbas (Family medicine 
registrar) 
Supervised by:   Dr. M. Namane (Senior Family 
Physician, Vanguard CHC) 
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ANNEXURE 3 
 
PHLEBOTOMY QUESTIONAIRE 2013 
 
DEMOGRAPHIC DATA: 
 
Age:…………………………………………………..   
Occupation:………………………………………. 
Rank:………………………………………………….  
Years of experience in phlebotomy:………………….. 
   
 
Read each question carefully and choose the correct answer. Make a “x” in the correct box. 
 
1. It is important to check your phlebotomy equipment before proceeding with drawing 
blood. 
⃝ True 
⃝ False 
 
2. Please circle the number that represents your confidence in drawing blood at your 
facility. 
 
Not confident at all                                                      Very confident 
                 1                      2                 3                  4             5              6 
 
3. A blood sample, if refrigerated should be stored at the following temperature to 
preserve the sample integrity. 
⃝ 5 - 10⁰C 
⃝ 2 - 8⁰C 
⃝ 1 - 10⁰C 
⃝ 37 – 38 ⁰C 
 
4. Blood sample tubes should ideally be kept in the fridge. 
⃝ True 
⃝ False 
 
5. CD4 blood samples once drawn should be kept in the fridge 
⃝ True  
⃝ False 
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PHLEBOTOMY QUESTIONAIRE 2013 
6. The correct order of draw of blood samples are as follows: 
⃝ purple, yellow, blue, grey 
⃝ purple, blue, yellow, grey 
⃝ blue, purple, yellow, grey 
⃝ yellow, blue, grey, purple 
 
7. Choose the correct option. 
The following areas should be avoided when drawing blood except: 
⃝ scars from burns and previous surgery 
⃝ veins from the antecubital fossa 
⃝ blood from a haematoma 
⃝ site where an intravenous line is placed 
⃝ oedematous extremities 
 
8. If a superficial vein is not easily seen/felt, you can: 
⃝ Ask the patient to elevate their arm for a few seconds 
⃝ Wash the patient’s hand with cold water 
⃝ Tap the vein with one/two fingers and place a warm damp cloth onto the vein 
⃝ Gently massage the arm from the shoulder to the wrist 
 
9. When drawing blood, the tourniquet should be placed: 
⃝ 1-2cm from the puncture site 
⃝ 5cm from the puncture site 
⃝ 3-4cm from the puncture site 
⃝ 6-8cm from the puncture site 
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PHLEBOTOMY QUESTIONAIRE 2013 
10. The tourniquet should not be left on the arm for more than:  
⃝ 2 minutes 
⃝ 10 minutes 
⃝ 5 minutes 
⃝ 30 seconds 
 
11. The angle of insertion of the needle into the patient’s arm should be: 
⃝ 45⁰ 
⃝ 15 - 30⁰ 
⃝ 90⁰ 
⃝ 10 -20⁰ 
 
12. When should the tourniquet be released? 
⃝ while the first tube is filling 
⃝ 1 min after the last tube is filling 
⃝ when the last tube is filling 
⃝ immediately after the last tube is filled 
 
13. Choose the correct option: 
⃝ Blood samples should be mixed vigorously atleast 8 times 
⃝ Blood samples should be mixed gently 8 -10 times 
⃝ Blood samples should be inverted atleast once 
⃝ Blood samples should be shaken to ensure adequate mixing of the sample 
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PHLEBOTOMY QUESTIONAIRE 2013 
14. Factors that result in haemoconcentration include all of the following:  
prolonged tourniquet time,  squeezing a puncture site,  intravenous therapy 
⃝ True 
⃝ False 
 
15. A haematoma can be prevented by: 
⃝ Applying pressure to the puncture site 
⃝ Forcefully drawing back the plunger of the syringe until the blood starts frothing 
⃝ Removing the needle before removing the tourniquet 
  
16. Which of the following results in blood sample rejection: 
⃝ Haemolysis 
⃝ No facility name on request form 
⃝ Cracked sample tube 
⃝ Some of the above 
⃝ All of the above 
 
17. Haemolysis can be prevented by the use of a luer adaptor attached to a butterfly needle. 
⃝ True 
⃝ False 
 
18. Samples should be transported in a sealed packet with one specimen per packet. 
⃝ True 
⃝ False 
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PHLEBOTOMY QUESTIONAIRE 2013 
19. Blood samples should be kept out of direct sunlight. 
⃝ True 
⃝ False 
 
20. Look at the blood sample and request form.  
Would this sample be accepted or rejected by the laboratory? 
⃝ Accepted 
⃝ Rejected 
 [A completed request form and an expired sample tube will be provided, the correct 
answer to the question above will be: rejected as a result of an expired tube] 
The staff are expected to know that they need to check the expiry date on the tube. 
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ANNEXURE 4 
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
TITLE OF THE RESEARCH PROJECT:   The development and 
implementation of a phlebotomy training session for primary health care 
workers and evaluating whether it is associated with a decrease in the 
rejection rate of blood samples sent to the laboratory.  
  
REFERENCE NUMBER:    ABBMUM001  
PRINCIPAL INVESTIGATOR:    Mumtaz Abbas 
ADDRESS: University of Cape Town – School 
of Public Health and Family 
Medicine 
CONTACT NUMBER:     082 491 9048/ 021 633 3250  
 
Good Day 
My name is Dr. Mumtaz Abbas. I am a postgraduate student in the Department of 
Family Medicine at the University of Cape Town. 
I would like to invite you to participate in a research project. Please read the 
information presented here and feel free to ask any questions. Also, your 
participation is entirely voluntary and you are free to decline to participate.  If you say 
no, this will not affect you negatively in any way whatsoever.  You are also free to 
withdraw from the study at any point, even if you do agree to take part. 
This study has been approved by the Human Research Ethics Committee (HREC) at 
the University of Cape Town (HREC REF: 549/2013). The HREC is located at Room 
E52-24 Groote Schuur Hospital, Old Main Building, Observatory 7925. Contact no: 
021 406 6338. 
 
What is the research study all about? 
There are many blood samples that are rejected at primary health care facilities, the 
cause of these rejections are related to phlebotomy technique. This study aims to 
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look at whether phlebotomy training is associated with a decrease in the rejection 
rate of blood samples sent to the laboratory. 
 
This study will consist of a phlebotomy training session of approximately 2 hours and 
a pre and post training questionnaire, comprising of 20 questions which will evaluate 
your knowledge and experience of phlebotomy. The questionnaire will take 10-15 
minutes to complete.  
 
Will you benefit from taking part in this research? 
You will benefit from the training by gaining additional knowledge and strengthening 
skills needed to conduct phlebotomy at primary health care facilities. Your patients 
will also benefit from the skills by improved phlebotomy technique and not having to 
return to the clinic for a repeat blood sample resulting in better patient and staff 
satisfaction. 
 
Are there risks involved in your taking part in this research? 
There are no risks involved if you take part in this study.  
 
Who will have access to your study data? 
The information obtained will be protected, and treated as confidential. The identity 
of all participants will remain anonymous. The only people who will have access to 
the data will be the three researchers: Dr Mumtaz Abbas, Dr Mosedi Namane and Dr 
Fidele Mukinda. 
 
Will you be paid to take part in this study and are there any costs involved? 
You will not be remunerated for participating in this study and will not incur any costs 
by participating in the study. 
 
Declaration by participant 
 
By signing below, I …………………………………………… agree to take part in a 
research study entitled: The development and implementation of a phlebotomy 
training programme for primary health care workers and evaluating whether it 
 
 
43 
 
is associated with a decrease in the rejection rate of blood samples sent to the 
laboratory.  
 
I declare that: 
 I have read the information above and it is written in a language that I 
understand. 
 I understand that my participation in this study is voluntary. 
 I may choose to leave the study at any time and will not be penalised or 
prejudiced in any way. 
  
Signed at (place) ………………………………………… on (date) …………………… 
 
 
 
 
………………………………….    ……………………………........ 
Signature of participant     Signature of witness 
 
 
Dr. Mumtaz Abbas 
Principal Investigator 
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ANNEXURE 5 
INSTITUTION AUTHORISATION 
TITLE OF THE RESEARCH PROJECT:   The development and 
implementation of a phlebotomy training session for primary health care 
workers and evaluating whether it is associated with a decrease in the 
rejection rate of blood samples sent to the laboratory.  
REFERENCE NUMBER: ABBMUM001 
PRINCIPAL INVESTIGATOR:    Mumtaz Abbas 
ADDRESS: University of Cape Town – School 
of Public Health and Family 
Medicine  
CONTACT NUMBER:     082 491 9048/ 021 633 3250  
To whom it may concern, 
I ……………………………………………………………………………….. representing 
Mitchells Plain / Heideveld / Maitland / Hanover Park / Vanguard Community 
Health Centre in my capacity as Family Physician herewith authorize that this 
study be conducted in light of the principal investigator conducting a phlebotomy 
training session. I also herewith authorize the principal investigator to make use of 
patient records from the National Health Laboratory Service (NHLS) in order to 
obtain the rejection rate and reasons for blood sample rejection in order to conduct a 
audit to meet the aims and objectives of the research project. 
It is accepted by the principal researcher that all legal and ethical aspects of this 
study will be considered and mitigated as outlined in the presented study proposal 
and adhered to at all times. 
Signed at (name of facility) ......................…........…………….On(date)……………...... 
 
 ..............................................................   ............................................................  
 
Signature            Print Name in full 
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ANNEXURE 6 
RESEARCHER AND STAFF MEMBER CONFIDENTIALITY 
TITLE OF THE RESEARCH PROJECT:   The development and 
implementation of a phlebotomy training session for primary health care 
workers and evaluating whether it is associated with a decrease in the 
rejection rate of blood samples sent to the laboratory.  
  
REFERENCE NUMBER:    ABBMUM001 
PRINCIPAL INVESTIGATOR:    Mumtaz Abbas 
ADDRESS: University of Cape Town – School 
of Public Health and Family 
Medicine 
CONTACT NUMBER:     082 491 9048/ 021 633 3250  
 
 
I ______________________________________ understand and acknowledge that:  
 
1. I shall respect and maintain the confidentiality of all discussions, deliberations, 
patient care records and any other information generated in connection with 
individual patient care, risk management and/or peer review activities.  
 
2. It is my legal and ethical responsibility to protect the privacy, confidentiality 
and security of all medical records, proprietary information and other 
confidential information relating to the Provincial Government Western Cape 
Department of Health – The NHLS, the CHCs where the study will be 
conducted and its affiliates, including business, employment and medical 
information relating to our patients, members, employees and health care 
providers. 
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3. I shall only access or disseminate patient care information in the performance 
of my assigned duties and where required by or permitted by law, only with 
the express approval of my supervisor or designee. I shall make no voluntary 
disclosure of any discussion, deliberations, patient care records or any other 
patient care, peer review or risk management information, except to persons 
authorized to receive it. 
 
4. I agree to discuss confidential information only in the work place and only for 
job related purposes and to not discuss such information outside of the work 
place or within hearing of other people who do not have a need to know about 
the information. 
 
5. I understand that the law specially protects psychiatric and drug abuse 
records, and that unauthorized release of such information may make me 
subject to legal and/or disciplinary action. 
 
6. My obligation to safeguard patient confidentiality continues after my 
termination of services with the principal investigator 
 
I hereby acknowledge that I have read and understand the foregoing information and 
that my signature below signifies my agreement to comply with the above terms. In 
the event of a breach or threatened breach of the Confidentiality Agreement, I 
acknowledge that the University of Cape Town, its partners and affiliates involved in 
this study may, as applicable and as it deems appropriate, pursue disciplinary action 
via internal or external legal processes.  
 
Signed at (place) ......................…........…………….. On …………....……….. 2013. 
 
 ..............................................................   ............................................................  
 
Signature            Print Name in full 
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PART B: STRUCTURED LITERATURE REVIEW 
a) Objectives of Literature Review 
 To describe the role of health system performance in achieving millennium 
development goals 
 To describe laboratory sample rejection rates and related-reasons 
 To describe the impact  of Phlebotomy Training on blood sample rejection 
 
b) Literature Search Strategy 
Databases include: 
 Pubmed/Medline 
 Scopus 
 Ebsco 
 Google Scholar 
Keywords: 
 Blood sample rejection, haemolysis, chemistry and haematology, rejection 
rate, Cape Town, Western Cape, South Africa, improving rejection rate 
 Health systems research 
 National  Health Insurance, laboratory, rejected blood samples 
 Millennium Development Goals 
 Phlebotomy training 
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c) Literature Review 
The role of laboratory medicine in achieving millennium development goals 
 
The evaluation of the reasons for blood sample rejection and its impact on healthcare costs 
as well as costs to the staff and most importantly to the patient is a form of assessing health 
systems performance. This provides role players in the health system with policy options 
and practical information that can be used to improve the healthcare system performance. 
Role players vary from managers at primary care level to policy makers at a national level. 
Evaluation of health systems performance helps to improve the quality of health service 
delivery with the key feature being its link to decision making i.e. informing a decision within 
a health system in order to achieve its goal.1 
 
The Commission on Health Research for Development identified international health 
research partnerships as vital to advancing health in developing countries and promoting 
global health equity.2The World Health Organisation (WHO) and global ministerial summits 
have subsequently linked health research to achieving the United Nations Millennium 
Development Goals (MDG’s).3,4There is a lack of knowledge regarding the barriers in health 
systems that hinder the delivery of successful interventions and the strategies needed to 
overcome them.5Stronger health systems are vital to  achieving improved health outcomes. 
A report by the WHO Task force on Health Systems Research says it is “essential to channel 
most resources to address the preparedness of health systems to delivering interventions”.5 
 
Strengthening health systems in developing countries is essential in improving healthcare 
globally and in reaching the MDG’s. Most developing countries fall short of the 
requirements to implement the goals suggested by the WHO.6 The following are important 
components, proposed by the WHO, in strengthening health systems and in achieving an 
effective public health system: service delivery, financing, governance, the health 
workforce, information systems and supply management systems.7 
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One of the main goals in strengthening health systems include improving clinical health 
laboratories3 and this includes reducing the rejection of blood samples received by the 
laboratory.  
 
A conference evaluating a programme for strengthening laboratory management was held  
in Africa in 2009. The highlights of this conference was to “act now, act collectively and act 
differently to ensure sustainability of global health efforts to enhance laboratory networks 
and systems”8Acting now involves addressing the 3 pillars for disease prevention, control, 
and patient management which include public health, clinical medicine, and laboratory 
medicine. The most neglected pillar in developing countries is laboratory medicine and this 
is vital in clinical decision making and for disease control. The increase in funding for global 
health development9,10 provides an excellent opportunity to end the neglect of laboratory 
systems and services in global health in developing countries. Quality laboratory services 
and systems is important in strengthening health systems as laboratory medicine provides 
critical information that assists medical decision making for quality health care.8Acting 
collectively involves addressing laboratory strengthening in a holistic way and to form 
partnerships to support developing countries to strengthen laboratory systems. Acting 
differently involves recognising the importance of clear indicators in order to monitor 
progress in strengthening laboratory systems.8 
 
The first international conference of the African Society for Laboratory Medicine (ASLM) was 
held in Cape Town, South Africa in December 2012. The focus of the conference was to 
strengthen national laboratory health systems. The outcomes of this conference was that it 
aimed to meet the following targets by the year 2020: “certification of 30,000 laboratory 
staff, the harmonisation in the regulation of diagnostics in Africa’s five economic regions, 
the international accreditation of 250 laboratories, and the strengthening of an African 
Network of National Public Health Reference laboratories in 30 countries.”11 
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Laboratory sample rejection, related-reasons and impact on patient care 
Patient care and safety has become increasingly more important in laboratory 
medicine.12Clinical governance is a system where healthcare organisations are responsible 
for continuously improving the quality of services that positively impacts on patient 
care.12,13 It is described as “a framework through which organisations are accountable to 
continue to improve the quality of the service and safeguard high standards of care by 
creating an environment in which excellence in clinical care would flourish”.14 
Clinical laboratories are striving to decrease the rejection rate of unsuitable blood samples 
and to provide an excellent level of care with more attention on patient care and safety.13 
The International Organization for Standardisation defines laboratory error as “failure of a 
planned action to be completed as intended, or use of a wrong plan to achieve an aim, 
occurring at any part of the laboratory cycle, from ordering examinations to reporting 
results and appropriately interpreting and reacting to them”.15 
 
The National Health Laboratory Service (NHLS) is the provider of laboratory services to all 
public sector hospitals in South Africa and certain requirements are necessary before a 
sample can be successfully processed. Majority of blood samples are rejected as a result of 
pre-analytical errors and this accounts for up to 70% of laboratory errors.5  
 
Studies reported the following pre-analytical errors: Patient identification (labelling errors, 
no test specified on request form, illegible request, no ward specified); sample collection  
(clotting, insufficient volume or inadequate ratio of volume sample/anticoagulant, 
inappropriate sample container and haemolysis) and sample transport (storage conditions 
i.e. temperature, sample lost or not received by laboratory).12,13 
 
The prevalence of pre-analytical problems ranged between 0.2% - 0.75% with the most 
common errors being haemolysis, clotting, insufficient blood volume, wrong sample tube 
and misidentification.17 About 6.4% to 12% of patients received inappropriate care due to 
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laboratory errors, with up to 30% of errors resulting in patient discomfort, high 
hospital/healthcare costs as well as subjecting patients to re-sampling blood.16  
 
In a recent retrospective audit conducted at Tygerberg hospital in Cape Town, 481 of 32 910 
samples (1.46%) were rejected during the two week study period.12The main reasons for 
sample rejection were clotting (30%) and inadequate sample volume (22%).12 Over half the 
samples were repeated. In the repeat sample, the average time for the sample to reach the 
laboratory was 5 days. Clinical impact of sample rejection on patient care was assessed in 30 
patients whose hospital folders were randomly selected included: pre-operative 
unavailability of results, 4 of 30 (13.3%); delayed initiation of phototherapy, 2 of 30 (6.7%); 
delayed transfusion, 2 of 30 (6.7%), delayed laboratory evaluation of patient on admission, 3 
of 30 (10%); no specific intervention, 18 of 30 (60%) and prolonged (unnecessary) 
treatment, 1 of 30 (3.3%).12 
 
In the same audit discussed above, 98 out of 481 samples (20.3%) were rejected as a result 
of incorrect patient identification errors and 70 out of 481 samples (14.6%) were rejected as 
a result of sample transport errors.12 
Haemolysis refers to the release of haemoglobin and intracellular components from 
erythrocytes into the surrounding plasma when the cell membrane is either damaged or 
disrupted.18Haemolysis account for 40-70% of all unsuitable blood samples sent to the 
laboratory and is much higher than any other causes such as clotted samples, incorrect 
blood volume, and incorrect sample tubes used. 18Not all samples that are haemolysed are 
rejected by the laboratory, many samples can still be processed successfully except for 
electrolytes like potassium and other tests that are influenced by haemolysis.18 
 
The low rate of repeating blood sample of rejected samples and delay in repeating the 
blood sample is also a concern as laboratory results can influence clinical decisions and 
inherent patient care.19 Turnaround times in repeating rejected samples can improve with 
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access to the NHLS DISA Laboratory (DISALAB) on site where clinicians can check results 
during the current hospital visit.12 
 
Critical values is defined as a “result suggestive of imminent danger to the patient unless 
appropriate therapy is promptly initiated”.20 Strategies need to be instituted in order to 
reduce pre-analytical errors. Promotion of an awareness of the significant clinical and 
economic impact of pre-analytical errors can help to improve this problem. An awareness 
can be created by communication between clinicians and laboratory staff, using the current 
guidelines available on specimen sampling and education of staff may increase the 
awareness of the problem at the facility we work.21 
 
The impact of Phlebotomy Training on blood sample rejection 
The quality of a service can be determined by evaluating the success with which a service is 
delivered.22 Procedures that are deemed of high volume, high risk and expensive should be 
monitored by laboratories.23In primary health care centres, phlebotomy is considered a high 
volume and high risk procedure in terms of the volume of patients that require bloods 
drawn as well as the dangers of needlestick injuries to the healthcare provider and the 
consequences of incorrect phlebotomy technique as discussed previously. Phlebotomy can 
also be of high cost if blood samples are rejected due to various reasons. It has been shown 
that bloods drawn by trained laboratory personnel/phlebotomists have lower blood sample 
rejection rates when compared to health care workers who have not received training. Even 
with trained personnel; haemolysis, clotting and insufficient blood volume were the main 
causes for blood sample rejection.21 
 
Laboratory medicine plays a vital role in everyday clinical practice as well as in the long term 
follow up of our patients. Only appropriate samples received by the laboratory can be 
analysed.24 Programmes that evaluated laboratory quality has shown blood sample 
 
 
53 
 
rejection rates which vary from 0.3% in outpatient departments to 0.8% in hospital 
inpatients.21 
 
A study conducted at a government hospital in Bhavnagar showed that incorrect 
phlebotomy technique was the main reason for blood sample rejection. In order to improve 
the quality of samples received by the laboratory, the authors of the above study suggest 
that phlebotomists and laboratory staff develop a manual on proper phlebotomy technique 
for provide health care providers.24 
 
d) Summary or interpretation of literature 
From the literature, it is clear that many blood samples are rejected in the pre analytical 
phase of laboratory testing with haemolysis and clotting being two of the main reasons for 
rejection. Patient identification errors and sample transport errors account for a minority of 
rejected blood samples. Many haemolysed samples are still processed by the laboratory 
despite this not being a good quality sample resulting in an underestimation of haemolysis 
as a cause for blood sample rejection. These reasons can be corrected by good phlebotomy 
technique which can be reinforced with a training manual and practical demonstration. It is 
important to reduce the rejection rate of laboratory blood in order to reduce the escalating 
costs to the laboratory, health care facility and the patient and to reduce patient discomfort.  
 
One of the goals in strengthening health care systems in South Africa is to improve the 
functioning of clinical laboratories. This can be done by ensuring that good quality samples 
reach the laboratory and that staff are adequately trained by laboratory personnel on all 
aspects of phlebotomy that is required to ensure a sample of good quality.  
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Needs for further research 
Further research should assess the effect of phlebotomy training on blood sample rejection 
rate as well as the cost of rejected blood samples at primary health facilities. The impact of 
rejected blood samples on patient care should also be evaluated. Another aspect which 
would be very informative would be to train a group of health care providers on proper 
phlebotomy technique, and then follow this group up pre and post training to assess 
whether the blood sample rejection rate reduced post phlebotomy training. This will help to 
motivate for formal training of health care workers prior to allowing them to draw bloods 
on patients.  
 
A survey looking at patients’ experiences of phlebotomy will provide insight into what 
patients feelings, fears and anxieties are regarding phlebotomy. One could also gain insight 
into patients’ positive experiences of phlebotomy at primary health care facilities, what 
worked well as well as areas they feel should be improved on.  
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Abstract 48 
Background: 49 
There is an increasing amount of blood sample rejection at primary health care 50 
facilities (PHCFs) impacting negatively on the staff, facility, patient and laboratory 51 
costs.  52 
 53 
Aim: 54 
The primary objective was to determine the rejection rate and reasons for blood 55 
sample rejection at four PHCFs pre and post phlebotomy training. The secondary 56 
objective was to determine whether phlebotomy training improved knowledge 57 
amongst primary health care providers (HCPs) and to develop a tool for blood 58 
sample acceptability.  59 
 60 
Study Setting: 61 
Two Community Health Centres (CHCs) and two Community Day Centres (CDCs) 62 
in Cape Town.  63 
 64 
Methods: 65 
A quasi-experimental study design  66 
  67 
 68 
 69 
 
 
60 
 
Results: 70 
The sample rejection rate was 0.79% (n= 60) at CHC A, 1.13% (n= 45) at CHC B, 71 
1.64% (n= 38) at CDC C and 1.36% (n= 8) at CDC D pre training. The rejection rates 72 
remained approximately the same post training (p>0.05). 73 
 74 
The same phlebotomy questionnaire was administered pre and post training to 75 
HCPs. The average score increased from 63% (95% CI 6.97 - 17.03) to 96% (95% CI 76 
16.91 - 20.09) at CHC A (p 0.039), 58% (95% CI 9.09 – 14.91) to 93% (95% CI 17.64 – 77 
18.76) at CHC B (p 0.006), 60% (95% CI 8.84 – 13.13) to 97% (95% CI 16.14 – 19.29) at 78 
CDC C (p 0.001) and 63% (95% CI 9.81 – 13.33) to 97% (95% CI 18.08 – 19.07) at CDC 79 
D (p 0.001).  80 
 81 
Conclusion: 82 
There is no statistically significant improvement in the rejection rate of blood 83 
samples (p>0.05) post training despite knowledge improving in all HCPs 84 
(p <0.05).  85 
 86 
 87 
 88 
 89 
 90 
 91 
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Introduction 92 
There is an increasing amount of blood sample rejection at PHCFs which impacts 93 
negatively on the staff, facility, patient and laboratory and results in high healthcare 94 
costs. Patient care and safety has become increasingly more important in laboratory 95 
medicine.1 Clinical laboratories have a big role to play in the management and 96 
diagnosis of patients.2 Clinical laboratories are striving to reduce the rejection rate of 97 
unsuitable blood samples and to provide an excellent level of care with more 98 
attention on patient care and safety.3,4  99 
 100 
Approximately 70 to 80% of diagnoses are made in conjunction with laboratory tests. 101 
A delay in laboratory test results may result in delayed diagnoses, inappropriate or 102 
unnecessary treatment, increased risk to patient safety, high healthcare costs and 103 
time lost.5 The National Health Laboratory Service (NHLS) provides laboratory 104 
services to all public sector hospitals in South Africa and certain requirements are 105 
necessary before a sample can be successfully processed. There are three main 106 
phases to the testing of blood samples at the laboratory and these include the pre- 107 
analytical, analytical and post analytical phase. The pre-analytical phase includes all 108 
steps from the time the clinician orders a test to the time the test is analysed; the 109 
analytical phase refers to the analysis of the sample and the post analytical phase 110 
refers to the reporting and interpretation of the test result.6  111 
 112 
Studies reported the following pre-analytical errors: Patient identification (labelling 113 
errors, no test specified on request form, illegible request, no ward specified); sample 114 
collection (clotting, insufficient blood volume, inappropriate sample container, 115 
haemolysis) and sample transport (storage conditions i.e. incorrect temperature, 116 
sample lost or not received by the laboratory).1,3 117 
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Majority of blood samples are rejected as a result of pre-analytical errors and this 118 
accounts for up to 70% of laboratory errors.7,8,9 The prevalence of pre-analytical 119 
problems ranged between 0.2% and 0.75% with the most common errors being 120 
haemolysis, clotting, insufficient blood volume, wrong sample tube and 121 
misidentification.17 6.4% to 12% of patients received inappropriate care due to 122 
laboratory errors, with up to 30% of errors resulting in patient discomfort, high 123 
hospital/healthcare costs as well as subjecting patients to re-sampling blood.10  124 
 125 
A pilot audit at Vanguard CHC in August 2012 (unpublished) showed that blood 126 
sample rejection is predominantly related to incorrect phlebotomy technique. This 127 
contributes significantly to pre-analytical errors, as primary health care nurses do 128 
not receive formal phlebotomy training as part of their undergraduate training.  129 
 130 
In a recent retrospective audit conducted at Tygerberg hospital in Cape Town, 481 of 131 
32 910 samples (1.46%) were rejected during the two week study period.1The main 132 
reasons for sample rejection were clotting (30%) and inadequate sample volume 133 
(22%).1 Over half the samples were repeated and the average time for the sample to 134 
reach the laboratory was 5 days.  135 
 136 
Haemolysis refers to the release of haemoglobin and intracellular components from 137 
erythrocytes into the surrounding plasma when the cell membrane is either 138 
damaged or disrupted.11 Haemolysis accounts for 40 to 70% of all unsuitable blood 139 
samples sent to the laboratory. 11 Not all haemolysed samples are rejected by the 140 
laboratory, many samples can still be processed successfully except for electrolytes 141 
like potassium and other tests that are influenced by haemolysis.1 142 
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The low rate of repeating blood samples of rejected samples and the delay in 143 
repeating the blood sample is also a concern as laboratory results can influence 144 
clinical decisions and inherent patient care.12 Turnaround times in repeating rejected 145 
samples can improve with access to the NHLS DISA Laboratory (DISALAB) on site 146 
where clinicians can check results during the current hospital visit.1 147 
 148 
The evaluation of the reasons for blood sample rejection and its impact on healthcare 149 
costs as well as costs to the staff and most importantly to the patient is a form of 150 
assessing health systems performance. This provides role players in the health 151 
system with policy options and practical information that can be used to improve the 152 
healthcare system performance.13 One of the goals in strengthening health care 153 
systems in South Africa is to improve the functioning of clinical laboratories. 14This 154 
can be done by ensuring that good quality samples reach the laboratory and that 155 
staff are adequately trained by laboratory personnel on all aspects of phlebotomy 156 
that is required to ensure a sample of good quality.  157 
 158 
The quality of a service can be determined by evaluating the success with which a 159 
service is delivered.15 Procedures that are deemed of high volume, high risk and 160 
expensive should be monitored by laboratories.16 In primary health care centres, 161 
phlebotomy is considered a high volume and high risk procedure in terms of the 162 
volume of patients that require bloods drawn as well as the dangers of needle stick 163 
injuries to HCPs and the consequences of incorrect phlebotomy technique.  164 
 165 
Phlebotomy can also be of high cost if blood samples are rejected due to various 166 
reasons. It was found that bloods drawn by trained laboratory 167 
personnel/phlebotomists have lower blood sample rejection rates when compared to 168 
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HCPs who have not received training (99.6% success vs 97.9%; p 0.002). Even with 169 
trained personnel; haemolysis, clotting and insufficient blood volume were the main 170 
causes for blood sample rejection.17 171 
 172 
Laboratory medicine plays a vital role in everyday clinical practice as well as in the 173 
long term follow up of our patients. Only appropriate samples received by the 174 
laboratory can be analysed.18 Programmes that evaluated laboratory quality has 175 
shown blood sample rejection rates vary from 0.3% in outpatient departments to 176 
0.8% in hospital inpatients.17 177 
 178 
A study conducted at a government hospital in Bhavnagar showed that incorrect 179 
phlebotomy technique was the main reason for blood sample rejection. In order to 180 
improve the quality of samples that reach the laboratory, the authors of the above 181 
study suggest that phlebotomists and laboratory staff develop a manual on proper 182 
phlebotomy technique for HCPs.18  183 
 184 
Aims and Objectives 185 
The aim was to assess the effect of phlebotomy training on blood sample rejection 186 
rate and knowledge among primary HCPs at four facilities in Cape Town. 187 
The primary objective of this study was to determine the rejection rate and reasons 188 
for blood sample rejection at four selected primary health care facilities pre and post 189 
phlebotomy training. The secondary objective was to determine whether 190 
phlebotomy training improved phlebotomy knowledge among primary HCPs and 191 
to develop a tool for blood sample acceptability. 192 
 193 
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Study design and methods 194 
Study design: 195 
We performed a quasi-experimental study where we measured HCPs knowledge on 196 
phlebotomy technique and laboratory blood sample rejection rates before and after a 197 
phlebotomy training programme. All blood samples received and rejected by the 198 
NHLS during the month of May 2014 (pre training) and July 2014 (post training) 199 
were included in the study. Any sample processed by the laboratory that was not 200 
blood was excluded from the study. 201 
 202 
Intervention: 203 
The phlebotomy training programme was developed based on the “NHLS Western 204 
Cape Regional Laboratories Specimen Sampling Manual 2013”. The programme was 205 
developed using the information in the manual regarding health and safety 206 
measures of phlebotomy, proper venepuncture technique, the correct way to handle 207 
blood samples and phlebotomy equipment such as needles and syringes, the correct 208 
storage and transport of blood samples as well as the correct completion of the 209 
NHLS sample request form.   210 
 211 
Selected HCPs were assigned to receive phlebotomy training as our intervention of 212 
interest. The phlebotomy training session was approximately two hours long and 213 
was conducted at each of the four facilities (CHC A, CHC B, CDC C and CDC D) at a 214 
pre-determined day and time during the month of June 2014. All HCPs who 215 
attended the training session received a copy of the “NHLS Western Cape Regional 216 
Laboratories Specimen Sampling Manual 2013”. 217 
 218 
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The same pre and post training questionnaire was completed by each HCP in 219 
attendance at the training to assess if their knowledge had improved post training. 220 
There was no pass mark however pre and post training scores determined whether 221 
knowledge around phlebotomy increased. 222 
 223 
Setting: 224 
The study was a multicentre study performed at four facilities in Cape Town, two 24 225 
hour CHCs (CHC A and B) and two 8 hour CDCs (CDC C and D).  226 
 227 
A community health facility (CHC and CDC) is a public primary health care facility 228 
funded by the government. It provides health care that covers a range of health 229 
promotion, disease prevention, curative and rehabilitative services to the 230 
community.19,20  231 
 232 
The facilities included CHC A and B, which were large 24h hour facilities serving 233 
between 150 000 and 300 000 patients 21,22 and CDC C and D, which were smaller 8 234 
hour facilities serving between 30 000 and 35 000 patients.23  235 
 236 
Study population and sampling strategy: 237 
The HCPs for the two hour phlebotomy training session were recruited by seeking 238 
their permission through the assistance of the facility managers and family 239 
physicians of the four facilities. Convenience sampling of HCPs were done, five 240 
HCPs from CHC A, seven from CHC B, seven from CDC C and four from CDC D. 241 
These HCPs were trained as trainers.  242 
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Data collection: 243 
The data for May 2014 (pre training) and July 2014 (post training) were extracted 244 
from the NHLS DISALAB at the data warehouse in Johannesburg. The data was 245 
captured into Microsoft® Excel®. The variables extracted  included the total number 246 
of routine blood samples performed, the number of blood samples rejected, the 247 
name of the test that was rejected (e.g full blood count) and the reason for rejected 248 
blood sample (e.g. clotted sample).  249 
 250 
Data from the data capture sheets were captured onto Microsoft Excel, was backed 251 
up on an external USB storage device which was only accessible to the principal 252 
investigator and research team. The data was encrypted and password protected 253 
within Microsoft Excel.  254 
 255 
A questionnaire with 20 closed ended questions (see Appendix A) was developed 256 
based on the NHLS phlebotomy training manual 2013 and input from experts 257 
working in PHCFs. The questionnaire was piloted by staff ordering blood 258 
investigations or involved in phlebotomy at Vanguard CHC and amended where 259 
necessary. The questionnaire was either in English or Afrikaans.  260 
 261 
Data Analysis: 262 
STATISTICATM version 14 was used for data analysis. The summary statistics was 263 
used to describe the variables. A test of proportion was performed to assess the 264 
effect of the intervention on the rejection rate of blood samples before and after 265 
training. The pre and post training questionnaire scores were analysed using the 266 
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Wilcoxon signed-rank test for non-parametric paired data. A p-value of < 0.05 267 
represented statistical significance 268 
 269 
Ethical considerations: 270 
This study has been approved by the Health Research Ethics Committee (HREC) of 271 
the University of Cape Town (HREC REF: 549/2013) as well as by the Provincial 272 
Government of the Western Cape (REF: 2013RP190). The study was conducted 273 
according to the Declaration of Helsinki.  274 
 275 
Results 276 
Approximately six to ten HCPs participated at these different sites. There were 23 277 
study participants (Table 1) who attended the phlebotomy training session across all 278 
the facilities, mostly aged between 30 to 50 years. There was only one male 279 
participant and twenty two females. There were three student nurses, seventeen 280 
nurses and only three doctors. The phlebotomy experience across participants 281 
varied, with nine participants having less than five years’ experience, five having 282 
five to ten years’ experience and nine having more than 30 years’ experience.  283 
 284 
Box 1 describes the tool that was developed to facilitate the training listing all the 285 
criteria for laboratory blood sample acceptability. 286 
 287 
 288 
 289 
 290 
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Table 1: Demographic data of study participants across all four clinics 291 
Category Participants’ n (%) 
Rank 
- Student Nurse 
- Nurse 
- Doctor 
 
 
 
3 (13) 
17 (74) 
3 (13) 
Sex 
- Male 
- Female 
 
1 (5)  
22 (95) 
 
 
Age 
- <30 years 
- 30 – 50 years 
- >50 years 
- Unknown 
 
 
7 (30) 
9 (39) 
5 (22) 
2 (9) 
Phlebotomy Experience 
- <5 years 
- 5 – 10 years 
- >10 years 
 
 
9 (39) 
5 (22) 
9 (39) 
 
 292 
 293 
 294 
 295 
 296 
 297 
 298 
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Box 1: ABBAS tool©  299 
 300 
ABBAS tool© compiled by: Drs Abbas, Namane and Mukinda 301 
 302 
1. REQUEST FORM 
 Name of facility 
 Diagnosis 
 Name of requesting doctor 
 Date and time of sample collection 
 HCP who took sample 
 Test specified on request form 
 Legible request 
 Patient’s details (first name & surname, folder no, age/DOB, sex) 
 Correct sample type for test requested 
 Doctor’s signature 
 INR sample – working contact number of patient or doctor 
 
2. SAMPLE  
 Tube not expired (check expiry date on tube)/cracked 
 Correct colour tube 
 Labelled sample (sticker placed lengthwise, NOT covering cap): 
First name and surname, folder number OR sticker if available 
 Do not pre-label before drawing blood 
 Patient’s name on form and sample matching 
 Correct volume of blood (check volume required on tube) 
 Gentle mixing of sample 8-10 times 
 Sample tubes kept at room temperature, NO direct sunlight 
 Samples kept at room temperature, IN FRIDGE if after hours 
 
3. SAMPLE TRANSPORT 
 Sealed packet 
 Blood sample/s and request form of index patient  in one packet 
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The total number of blood samples included in the study during May 2014 (pre 303 
training): 7557 from CHC A, 3973 from CHC B, 2321 from CDC C and 589 from CDC 304 
D. The total number of blood samples included in the study during July 2014 (post 305 
training): 10218 from CHC A, 4114 from CHC B, 2279 from CDC C and 630 from 306 
CDC D.  307 
 308 
During the month of May 2014 (Table 2): 60 of 7557 blood samples (0.79%) were 309 
rejected pre training at CHC A and 79 of 10218 blood samples  (0.77%) post training 310 
(p 0.971). CHC A is the largest of the four facilities. Only eight of 589 blood samples 311 
(1.36%) were rejected pre training at CDC D and seven of 630 blood samples (1.11%) 312 
post training (p 0.696). CDC D is the smallest of the four facilities.  313 
 314 
The reasons for blood sample rejection were grouped into four main categories 315 
including technique related, knowledge related, request form related and 316 
unaccountable pre-analytical errors. Technique related errors include samples that 317 
were clotted or haemolysed. Knowledge related errors include errors due to 318 
incorrect blood volume or the incorrect blood sample tube used. Request form errors 319 
include any error in the completion of the request form such as no patient details 320 
Table 2: Rejection rate of blood samples pre and post phlebotomy training 
Pre Phlebotomy Training 
May 2014 
Post Phlebotomy Training 
July 2014 
CHC/CDC Blood 
Registrations 
Blood 
Rejections 
n (%) 
Blood 
Registrations 
Blood 
Rejections 
n (%) 
P value 
A 7557 60 (0.79) 10218 79 (0.77) 0.876 
B 3973 45 (1.13) 4114 48 (1.17) 0.886 
C 2321 38 (1.64) 2279 37 (1.62) 0.971 
D 589 8   (1.36) 630 7   (1.11) 0.696 
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indicated, illegible requests, name on sample tube and request form unmatched, no 321 
test requested or an unlabelled sample. Unaccountable pre-analytical errors include 322 
all errors that are not accounted for by the above but that occur in the pre-analytical 323 
phase of laboratory testing of blood samples. These include samples with missing 324 
rejection reasons, samples older than three days, samples that leaked in transit as 325 
well as samples that were not received by the laboratory.  326 
 327 
Table 3 provides a detailed summary of rejection rates and related-reasons by 328 
facility. At CHC A, many samples were rejected due to clotting, 20 (0.26%) were 329 
rejected pre training and 16 (0.16%) post training (Table 3). Request form errors 330 
improved post training from 11 (0.15%) pre training to eight (0.08%) post training. 331 
There was an increase in the rejection rate of samples due to unaccountable pre-332 
analytical errors, 17 (0.22%) pre training to 27 (0.26%) post training (Figure 1).  333 
 334 
At CHC B, knowledge related errors reduced from 16 (0.40%) rejected samples pre 335 
training to nine (0.22%). Twelve samples (0.16%) were rejected due to ‘incorrect 336 
sample tube’. This was reduced by half (0.15%) post training. However all other 337 
reasons for blood sample rejection increased post training (Figure 2).  338 
 339 
At CDC C, many samples were rejected due to clotting pre and post training with 340 
the rejection rate increasing post training. Knowledge related errors reduced from 341 
five (0.02%) rejected samples pre training to three (0.13%). Request form errors 342 
doubled from three (0.13%) rejected samples pre training to six (0.26%). 343 
Unaccountable pre-analytical errors, due to ‘age of sample>3 days’ also contributed 344 
to many of the sample rejection, 11 (0.04%) rejected samples pre training and seven 345 
(0.31%) post training (Figure 3).  346 
 347 
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CDC D is a smaller 8 hour facility compared to CDC C and only had four out of 589 348 
(0.68%) samples rejected due to clotting pre training, which was reduced to two 349 
(0.32%). Unaccountable pre-analytical errors reduced by half post training. There 350 
were no request form errors pre or post training (Figure 4).  351 
 352 
The overall rejection rate, irrespective of facility, showed an increase in the rejection 353 
rate post training, which was not statistically significant (p >0.05) (Table 4). 354 
 355 
 356 
 357 
 358 
 359 
 360 
 361 
 362 
 363 
 364 
 365 
 366 
 367 
 368 
 369 
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Table 3: Rejection rate and reasons for blood sample rejection pre and post 370 
phlebotomy training by facility 371 
                                   Pre Phlebotomy Training 
                                   May 2014 
                                  n (%) 
Post Phlebotomy Training 
July  2014 
n (%) 
Reasons for rejection CHC A        CHC B      CDC C       CDC D CHC A      CHC B      CDC C        CDC D 
Technique related 
- clotted 
- haemolysed 
20 (0.26)    8 (0.20)    15 (0.65)    4 (0.68) 
20 (0.26)    7 (0.18)    15 (0.65)    4 (0.68) 
0                 1 (0.01)      0               0 
 
20 (0.20)  15 (0.36)  18 (0.79)  2 (0.32) 
16 (0.16)  14 (0.34)  16 (0.70)  2 (0.32) 
4 (0.04)     1 (0.02)     2 (0.09)   0 
Knowledge related 
- incorrect blood 
volume 
- incorrect sample tube 
12 (0.16)   16 (0.40)    5 (0.02)      0 
5 (0.07)      4 (0.10)     2 (0.09)      0 
 
7 (0.09)     12 (0.30)    3 (0.13)      0 
24 (0.23)    9 (0.22)    3 (0.13)     3 (0.48) 
8 (0.08)      3 (0.07)    1 (0.04)     1 (0.16) 
 
16 (0.16)    6 (0.15)   2 (0.09)     2 (0.32) 
 
Request form errors 
- name on form and 
sample unmatched 
- no patient details 
- no test requested 
- illegible request 
- unlabelled sample 
- no reason stated 
 
 
11 (0.15)   11 (0.28)    3 (0.13)      0 
3 (0.04)      1 (0.03)      1 (0.04) 
 
1 (0.01)       0                 0 
1 (0.01)       3 (0.08)      1 (0.04) 
1 (0.01)       0                 0 
5 (0.07)       3 (0.08)      0 
0                  4 (0.10)      1 (0.04) 
 
8 (0.08)      12 (0.29)  6 (0.26)     0 
4 (0.04)       4 (0.10)   0 
 
0                   0              0 
2 (0.02)        0              1 (0.04) 
0                   0              0 
2 (0.02)        5 (0.12)    3 (0.13) 
0                  3 (0.07)    2 (0.09) 
Unaccountable pre-
analytical errors 
- no reason stated 
- sample leaked 
- no sample received 
- age of sample >3 days 
17 (0.22)   10 (0.25)    15 (0.65)    4(0.68) 
 
11 (0.15)      0               0                0 
2 (0.03)        0               0                0 
1(0.01)    2(0.05)       4(0.17)        4(0.68) 
3 (0.03)   8 (0.20)    11 (0.04)         0 
27 (0.26)   12 (0.29)  10 (0.44)    2 (0.32) 
 
18 (0.18)    0                0              1 (0.16) 
1 (0.01)      1 (0.02)     0               0 
5 (0.05)      6 (0.15)    3 (0.13)     1 (0.16) 
3 (0.03)      5 (0.12)    7 (0.31)     0 
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 372 
 373 
Figure 1: The rejection rate at CHC A 374 
 375 
 376 
 377 
 Figure 2: The rejection rate at CHC B 378 
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 379 
 380 
Figure 3: The rejection rate at CDC C 381 
 382 
 383 
Figure 4: The rejection rate at CDC D 384 
 385 
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Table 4: Overall rejection rates and related reasons for all facilities combined 387 
                                                Pre Phlebotomy            
                                           Training 
                                             May 2014 
                                           
Post Phlebotomy 
Training 
July  2014 
 
   
Related reason for 
rejection 
Rejection Rate 
n (%) 
Rejection rate 
n (%) 
P value 95% Confidence 
Interval  
  
Technique related 
 
47 (0.33%) 55 (0.32%) 0.38 -8 to 4   
Knowledge related 33 (0.23%) 39 (0.23%) 0.74 -14.39 to 11.39   
 
Request form errors 
 
 
25 (0.17%) 
 
26 (0.15%) 
 
0.85 
 
-4.23 to 3.73 
  
Unaccountable pre-
analytical errors 
 
46 (0.32%) 51 (0.30%) 0.73 -11.59 to 9.09   
 388 
The pre and post training questionnaire scores showed an improvement in 389 
Phlebotomy knowledge post training as the average percentage score increased 390 
across all clinics. The average score increased from 63% (95% CI 6.97 - 17.03) to 96% 391 
(95% CI 16.91 - 20.09) at CHC A (p 0.039), 58% (95% CI 9.09 – 14.91) to 93% (95% CI 392 
17.64 – 18.76) at CHC B (p 0.006), 60% (95% CI 8.84 – 13.13) to 97% (95% CI 16.14 – 393 
19.29) at CDC C (p 0.001) and 63% (95% CI 9.81 – 13.33) to 97% (95% CI 18.08 – 19.07) 394 
at CDC D (p 0.001).  395 
 396 
 397 
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Participants were asked to grade their level of confidence in phlebotomy on a Likert 398 
scale from 1 to 6, with 1 being ‘not confident at all’ and 6 being ‘very confident’. All 399 
participants’ level of confidence either remained the same or increased post 400 
phlebotomy training (Figure 5).  401 
 402 
Figure 5: Level of confidence in Phlebotomy across all clinics pre and post training 403 
using a Likert Scale 404 
 405 
Discussion  406 
The study found that an appropriate intervention such as phlebotomy training has 407 
improved knowledge regarding phlebotomy (p <0.05). The study results show no 408 
statistically significant improvement in the rejection rate of blood samples sent to the 409 
laboratory by each of the four PHCFs (p>0.05) post phlebotomy training. The overall 410 
rejection rate also showed no statistical significance in the rejection rate post training 411 
(p >0.05). 412 
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The sample rejection rate was 0.79% at CHC A, 1.13% at CHC B, 1.64% at CDC C and 413 
1.36% at CDC D pre-training. The rejection rates remained approximately the same 414 
post training. This could possibly be explained by other factors not explored in this 415 
quasi-experimental study. These factors include the phlebotomy experience of the 416 
primary HCPs, the same group of participants who received training were not 417 
followed up and participants who did not receive training were involved in 418 
phlebotomy post training which may have affected the study results. 419 
 420 
A large number of the blood samples in this study were rejected due to clotting 421 
which was also seen in a similar study in 2011 at Tygerberg hospital.1Pre-analytical 422 
errors is a major concern for laboratories accounting for up to 70% of laboratory 423 
errors4 hence the need for a sustainable intervention to improve such errors. 424 
However, despite haemolysis being a leading cause of blood sample rejection 425 
accounting for up to 70% of unsuitable samples11, this was not the leading cause of 426 
sample rejection in this study. From the overall rejection rates (Table 4), the leading 427 
cause of sample rejection was clotting which is related to phlebotomy technique, 428 
followed by unaccountable pre-analytical errors. It is difficult to correct 429 
unaccountable pre-analytical errors, since we do not always know why and how 430 
these errors occur.  431 
 432 
Since approximately 60% of clinical decisions are influenced by laboratory results12, 433 
an improvement in the rejection rate by improving pre-analytical errors should 434 
improve patient care. Apart from the impact that rejected blood samples has on 435 
patient care in terms of the patient’s management, it also has a financial impact on 436 
the facility as well as causing pain and emotional harm to the patient.24  437 
 438 
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It was interesting that there was only 1 male participant out of the 23 participants. 439 
Only three out of 23 participants were doctors. This may be due to the high patient 440 
volumes and insufficient time to attend a two hour training programme, or they may 441 
not feel they will learn something new as phlebotomy training is part of the 442 
undergraduate training programme as a medical student. For each of the 23 443 
participants, the pre and post training questionnaire scores improved. All 444 
participants’ level of confidence had improved or remained the same.  445 
 446 
Strengths and limitations 447 
HCPs who did not participate in the training were involved in blood sample 448 
collection post training which may have adversely affected the study results. 449 
Reasons for some of the rejected blood samples were not provided in the NHLS 450 
database. There is also an underestimation of haemolysis as a cause of blood sample 451 
rejection as many haemolysed samples are still processed and only the potassium is 452 
rejected, therefore the rejection rate might be higher than reported on in this study.   453 
 454 
Implications or recommendations 455 
Increased knowledge in phlebotomy does not in itself influence practice. We 456 
recommend that primary HCPs receive phlebotomy training in order to reduce the 457 
rejection rate of laboratory blood samples and that any training at primary level 458 
facilities be accompanied by support from managers and that regular monitoring 459 
and evaluation of systems be done. The above recommendation is supported by 460 
similar audits conducted at other PHCFs.25,26 461 
 462 
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Conclusion 463 
The study results show no statistically significant improvement in the rejection rate 464 
of blood samples sent to the laboratory by each of the four PHCFs (p>0.05) post 465 
phlebotomy training despite phlebotomy knowledge improving in all HCPs  466 
(p < 0.05).  467 
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Appendix A 592 
 593 
PHLEBOTOMY QUESTIONAIRE 2013 594 
 595 
DEMOGRAPHIC DATA: 596 
 597 
Age:…………………………………………………..   598 
Occupation:………………………………………. 599 
Rank:………………………………………………….  600 
Years of experience in phlebotomy:………………….. 601 
   602 
 603 
Read each question carefully and choose the correct answer. Make a “x” in the 604 
correct box. 605 
 606 
6. It is important to check your phlebotomy equipment before proceeding with 607 
drawing blood. 608 
⃝ True 609 
⃝ False 610 
 611 
7. Please circle the number that represents your confidence in drawing blood at 612 
your facility. 613 
 614 
Not confident at all                                                                 Very confident 615 
                 1                      2                 3                  4             5              6 616 
 617 
8. A blood sample, if refrigerated should be stored at the following temperature to 618 
preserve the sample integrity. 619 
⃝ 5 - 10⁰C 620 
⃝ 2 - 8⁰C 621 
⃝ 1 - 10⁰C 622 
⃝ 37 – 38 ⁰C 623 
 624 
9. Blood sample tubes should ideally be kept in the fridge. 625 
⃝ True 626 
⃝ False 627 
 628 
 629 
 630 
 631 
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10. CD4 blood samples once drawn should be kept in the fridge 632 
⃝ True  633 
⃝ False 634 
 635 
6. The correct order of draw of blood samples are as follows: 636 
⃝ purple, yellow, blue, grey 637 
⃝ purple, blue, yellow, grey 638 
⃝ blue, purple, yellow, grey 639 
⃝ yellow, blue, grey, purple 640 
 641 
7. Choose the correct option. 642 
The following areas should be avoided when drawing blood except: 643 
⃝ scars from burns and previous surgery 644 
⃝ veins from the antecubital fossa 645 
⃝ blood from a haematoma 646 
⃝ site where an intravenous line is placed 647 
⃝ oedematous extremities 648 
 649 
8. If a superficial vein is not easily seen/felt, you can: 650 
⃝ Ask the patient to elevate their arm for a few seconds 651 
⃝ Wash the patient’s hand with cold water 652 
⃝ Tap the vein with one/two fingers and place a warm damp cloth onto the vein 653 
⃝ Gently massage the arm from the shoulder to the wrist 654 
 655 
9. When drawing blood, the tourniquet should be placed: 656 
⃝ 1-2cm from the puncture site 657 
⃝ 5cm from the puncture site 658 
 
 
88 
 
⃝ 3-4cm from the puncture site 659 
⃝ 6-8cm from the puncture site 660 
 661 
10. The tourniquet should not be left on the arm for more than:  662 
⃝ 2 minutes 663 
⃝ 10 minutes 664 
⃝ 5 minutes 665 
⃝ 30 seconds 666 
 667 
11. The angle of insertion of the needle into the patient’s arm should be: 668 
⃝ 45⁰ 669 
⃝ 15 - 30⁰ 670 
⃝ 90⁰ 671 
⃝ 10 -20⁰ 672 
 673 
12. When should the tourniquet be released? 674 
⃝ while the first tube is filling 675 
⃝ 1 min after the last tube is filling 676 
⃝ when the last tube is filling 677 
⃝ immediately after the last tube is filled 678 
 679 
13. Choose the correct option: 680 
⃝ Blood samples should be mixed vigorously atleast 8 times 681 
⃝ Blood samples should be mixed gently 8 -10 times 682 
⃝ Blood samples should be inverted atleast once 683 
⃝ Blood samples should be shaken to ensure adequate mixing of the sample 684 
 685 
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14. Factors that result in haemoconcentration include all of the following:  686 
prolonged tourniquet time,  squeezing a puncture site,  intravenous therapy 687 
⃝ True 688 
⃝ False 689 
 690 
15. A haematoma can be prevented by: 691 
⃝ Applying pressure to the puncture site 692 
⃝ Forcefully drawing back the plunger of the syringe until the blood starts frothing 693 
⃝ Removing the needle before removing the tourniquet 694 
  695 
16. Which of the following results in blood sample rejection: 696 
⃝ Haemolysis 697 
⃝ No facility name on request form 698 
⃝ Cracked sample tube 699 
⃝ Some of the above 700 
⃝ All of the above 701 
 702 
17. Haemolysis can be prevented by the use of a luer adaptor attached to a butterfly 703 
needle. 704 
⃝ True 705 
⃝ False 706 
 707 
18. Samples should be transported in a sealed packet with one specimen per packet. 708 
⃝ True 709 
⃝ False 710 
 711 
 712 
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19. Blood samples should be kept out of direct sunlight. 713 
⃝ True 714 
⃝ False 715 
 716 
20. Look at the blood sample and request form.  717 
Would this sample be accepted or rejected by the laboratory? 718 
⃝ Accepted 719 
⃝ Rejected 720 
[A completed request form and an expired sample tube will be provided, the correct 721 
answer to the question above will be: rejected as a result of an expired tube] 722 
The staff are expected to know that they need to check the expiry date on the tube. 723 
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Structure and style of your original research article 
The page provides an overview of the structure and style of your original research article to 
be submitted to the African Journal of Primary Health Care & Family Medicine. An original 
article provides an overview of innovative research in a particular field within or related to the 
focus and scope of the journal, presented according to a clear and well-structured format 
(between 3500 and 7000 words with a maximum of 60 references). 
When presenting your article in English. Please use British English, that is, according to 
the Oxford English Dictionary. Avoid Americanisms (e.g. use ‘s’ and not ‘z’ spellings). Consult 
the Oxford English Dictionary when in doubt and remember to set your version of Microsoft 
Word to UK English. 
 Language: Manuscripts must be written in British English or French. 
 Line numbers: Insert continuous line numbers. 
 Font type: Palatino  
 Symbols font type: Times New Roman  
 General font size: 12pt  
 Line spacing: 1.5 
 Headings: Ensure that formatting for headings is consistent in the manuscript. 
o First headings: normal case, bold and 14pt 
o Second headings: normal case, underlined and 14pt 
o Third headings: normal case, bold and 12pt 
o Fourth headings: normal case, bold, running-in text and separated by a colon. 
Our publication system supports a limited range of formats for text and graphics. Text files 
can be submitted in the following formats only: 
 Microsoft Word (.doc): We cannot accept Word 2007 DOCX files. If you have created your 
manuscript using Word 2007, you must save the document as a Word 2003 file before 
submission. 
 Rich Text Format (RTF) documents uploaded during Step 2 of the submission process. Users 
of other word processing packages should save or convert their files to RTF before uploading. 
Many free tools are available that will make this process easier. 
 For full details on how to ensure your manuscript adheres to the house style, click here. 
The structure and style of your original article 
Page 1 
The format of the compulsory cover letter forms part of your submission, is on the first 
page of your manuscript and should always be presented in English. You should provide all of 
the following elements: 
 
 
92 
 
 Full author details: Provide title(s), full name(s), position(s), affiliation(s) and contact 
details (postal address, email, telephone and cellular number) of each author.  
 Corresponding author: Identify to whom all correspondence should be addressed. 
 Summary: Lastly, a list containing the number of words, pages, tables, figures and/or other 
supplementary material should accompany the submission. 
Page 2 and onwards 
Title: The article’s full title should contain a maximum of 95 characters (including spaces). 
Abstract: The abstract, written in English and French, should be no longer than 250 words 
and must be written in the past tense. The abstract should give a succinct account of the 
objectives, methods, results and significance of the matter. The structured abstract for an 
Original Research article should consist of six paragraphs labelled Background, Aim, Setting, 
Methods, Results and Conclusion. The journal can translate into French if this is difficult for 
you. 
 Background: Summarise the social value (importance, relevance) and scientific value 
(knowledge gap) that your study addresses. 
 Aim: State the overall aim of the study. 
 Setting: State the setting for the study. 
 Methods: Clearly express the basic design of the study, and name or briefly describe the 
methods used without going into excessive detail. 
 Results: State the main findings. 
 Conclusion: State your conclusion and any key implications or recommendations. 
Do not cite references and do not use abbreviations excessively in the abstract. 
The following headings serve as a guide for presenting your research in a well-structured 
original article. As an author you should include all first-level headings, but subsequent 
headings (second- and third-level headings) can be changed. 
Introduction (first-level heading) 
The introduction must contain your argument for the social and scientific value of the study, 
as well as the aim and objectives: 
Social value: The first part of the introduction should make a clear and logical argument for 
the importance or relevance of the study. Your argument should be supported by use of 
evidence from the literature. 
Scientific value: The second part of the introduction should make a clear and logical 
argument for the originality of the study. This should include a summary of what is already 
known about the research question or specific topic, and should clarify the knowledge gap 
that this study will address. Your argument should be supported by use of evidence from the 
literature. 
Conceptual framework: In some research articles it will also be important to describe the 
underlying theoretical basis for the research and how these theories are linked together in a 
conceptual framework. The theoretical evidence used to construct the conceptual framework 
should be referenced from the literature.  
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Aim and objectives: The introduction should conclude with a clear summary of the aim and 
objectives of this study. 
Research methods and design (first-level heading) 
The methods should include: 
Study design (second-level heading): An outline of the type of study design. 
Setting (second-level heading): A description of the setting for the study; for example, 
the type of community from which the participants came or the nature of the health system 
and services in which the study is conducted. 
Study population and sampling strategy (second-level heading): Describe the study 
population and any inclusion or exclusion criteria. Describe the intended sample size and your 
sample size calculation or justification. Describe the sampling strategy used. Describe in 
practical terms how this was implemented. 
Intervention (if appropriate) (second-level heading): If there were intervention and 
comparison groups, describe the intervention in detail and what happened to the comparison 
groups.  
Data collection (second-level heading): Define the data collection tools that were used 
and their validity. Describe in practical terms how data were collected and any key issues 
involved, e.g. language barriers. 
Data analysis (second-level heading): Describe how data were captured, checked and 
cleaned. Describe the analysis process, for example, the statistical tests used orsteps 
followed in qualitative data analysis. 
Ethical considerations (second-level heading): Approval must have been obtained for all 
studies from the author's institution or other relevant ethics committee and the institution’s 
name and permit numbers should be stated here. 
Results (first-level heading) 
Present the results of your study in a logical sequence that addresses the aim and objectives 
of your study. Use tables and figures as required to present your findings. Use quotations as 
required to establish your interpretation of qualitative data. 
All units should conform to the SI convention and be abbreviated accordingly. Metric units 
and their international symbols are used throughout, as is the decimal point (not the decimal 
comma). 
Discussion (first-level heading) 
The discussion section should address the following four elements: 
Key findings: Summarise the key findings without reiterating details of the results. 
Discussion of key findings: Explain how the key findings relate to previous research or to 
existing knowledge, practice or policy. 
Strengths and limitations: Describe the strengths and limitations of your methods and 
what the reader should take into account when interpreting your results. 
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Implications or recommendations: State the implications of your study or 
recommendations for future research (questions that remain unanswered), policy or practice. 
Make sure that the recommendations flow directly from your findings. 
Conclusion (first-level heading)  
Provide a brief conclusion that summarises the results and their meaning or significance in 
relation to each objective of the study. 
Acknowledgements (first-level heading)  
If, through your study, you received any significant help in conceiving, designing or carrying 
out the work, or received materials from someone who did you a favour by supplying them, 
you must acknowledge their assistance and the service or material provided. Authors 
should always acknowledge outside reviewers of their drafts and any sources of 
funding that supported the research. 
Competing interests (second-level heading): A competing interest exists when your 
interpretation of data or presentation of information may be influenced by your personal or 
financial relationship with other people or organisations that can potentially prevent you from 
executing and publishing unbiased research. Authors should disclose any financial competing 
interests but also any non-financial competing interests that may cause them embarrassment 
were they to become public after the publication of the manuscript. Where an author has 
no such competing interests, the listing will read as follows: ‘The authors declare that 
they have no financial or personal relationship(s) that may have inappropriately influenced 
them in writing this article.’    
Authors' contributions (second-level heading): This section is necessary to give 
appropriate credit to each author, and to the authors' applicable institution. The individual 
contributions of authors should be specified with their affiliation at the time of the study and 
completion of the work. An ‘author’ is generally considered to be someone who has made 
substantive intellectual contributions to a published study. Contributions made by each of the 
authors listed can follow the example below (please note the use of authors’ initials): 
J.K. (University of Pretoria) was the project leader, L.M.N. (University of KwaZulu-Natal) and 
A.B. (Stellenbosch University) were responsible for experimental and project design. L.M.N. 
performed most of the experiments. P.R. (Cape Peninsula University of Technology) made 
conceptual contributions and S.T. (University of Cape Town), U.V. (University of Cape Town) 
and C.D. (University of Cape Town) performed some of the experiments. S.M. (Cape 
Peninsula University of Technology) and V.C. (Cape Peninsula University of Technology) 
prepared the samples and calculations were performed by C.S. (Cape Peninsula University of 
Technology). 
References (first-level heading)  
Begin the reference list on a separate page, and give no more than 60 references in all. 
The African Journal of Primary Health Care & Family Medicine uses the Vancouver 
referencing style, details of which can be downloaded from the journal website. Note: No 
other style will be permitted. 
Systematic reviews 
Systematic reviews should follow the same basic structure as other original research articles 
as described above. The aim and objectives should specific the focused clinical question that 
will be addressed in the review. The methods section should describe in detail the search 
 
 
95 
 
strategy, criteria used to select or reject articles, attempts made to obtain all important and 
relevant studies and deal with publication bias (including grey and unpublished literature), 
how the quality of included studies was appraised, the methodology used to extract and/or 
analyse data. Results should describe the homogeneity of the different findings, clearly 
present the overall results and any meta-analysis.  
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PART D: SUPPORTING DOCUMENTS 
Please find the following supporting documents attached to “Part A: The Protocol” above: 
1. Annexure 1: Data Capture Sheet 
2. Annexure 2: The Intervention 
3. Annexure 3: Phlebotomy Questionnaire 2013 
4. Annexure 4: Participant information leaflet and consent form 
5. Annexure 5: Institution Authorisation 
6. Researcher and staff member confidentiality form 
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